Atlas Trials

Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma

Clinical trial NCT01484626 · TERMINATED

Trial details

NCT number
NCT01484626
Sponsor
Loyola University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2011-05-05
Primary completion
2014-06-18
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.